Hutchison China Meditech

Developer of immunotherapies for the treatment of cancer and immunological diseases

placeHong Kong, Hong Kong, China calendar_todayFounded 2005 groups1,990 employees language hutch-med.com

Innovation

1 patent family — focus: Chemistry & metallurgy; filing pace dormant.

YearFilings
20201

Social engagement

Social engagement: 13.9K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

5 investors on record; 1 has since exited.

Investor typeCountShare
Private equity480%
Other / undisclosed120%

Recent activity

25 Jun 2026
Event
European Society for Medical Oncology Gastrointestinal Cancers Congress #ESMOGI26
22 May 2026
Event
American Society of Clinical Oncology #ASCO26 Annual Meeting
21 May 2026
Milestone
regulatory
Coming soon